Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Rilpivirine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Laurus’s Generics Emtricitabine Receives Approval in US
    Laurus’s Generics Emtricitabine Receives Approval in US

    04 Mar 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220232

    FDA
    04 Mar 2026
    Share Share
    GSK Props Up Its Cabenuva In Adolescents With Long-Term Data
    GSK Props Up Its Cabenuva In Adolescents With Long-Term Data

    26 Feb 2026

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/gsks-viiv-confirms-staying-power-long-acting-hiv-treatment-cabenuva-adolescents

    FIERCE PHARMA
    26 Feb 2026
    Share Share
    ViiV Health: Long-Acting Cabenuva Maintains HIV Control in Teens
    ViiV Health: Long-Acting Cabenuva Maintains HIV Control in Teens

    26 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-26/viiv-healthcare-reports-long-acting-injectable-cabenuva-effectively-maintains-viral-suppression-in-adolescents-living-with-hiv-with-97-preferring

    PHARMIWEB
    26 Feb 2026
    Share Share
    Viiv Pharma Unveils Long-Acting HIV Breakthroughs At CROI 2026
    Viiv Pharma Unveils Long-Acting HIV Breakthroughs At CROI 2026

    17 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260217311861/en/ViiV-Healthcare-showcases-long-acting-HIV-innovation-and-potential-of-ultra-long-acting-pipeline-including-new-data-for-first-third-generation-integrase-inhibitor-at-CROI-2026

    BUSINESSWIRE
    17 Feb 2026
    Share Share
    Apotex’s Receives First Generic Approval for Emtricitabine in US
    Apotex’s Receives First Generic Approval for Emtricitabine in US

    30 Jan 2026

    // FDA

    http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=214095

    FDA
    30 Jan 2026
    Share Share
    Somerset’s Receives First Generic Approval for Rilpivirine in US
    Somerset’s Receives First Generic Approval for Rilpivirine in US

    29 Jan 2026

    // FDA

    http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=218798

    FDA
    29 Jan 2026
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.